Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Tradition Meets Innovation -­ Greiner Bio-One Celebrates 50 Successful Years

Published: Friday, December 13, 2013
Last Updated: Thursday, December 12, 2013
Bookmark and Share
Company now has over 1,700 employees spread across seven production facilities.

This year marks the 50th anniversary of Greiner Bio-One GmbH. Over the past five decades, the business founded in Nürtingen, Germany, as Greiner Labortechnik has become an international high-tech company, but it has never lost sight of its modest SMB roots.

Combining tradition with innovation has created a globally successful technology partner for the diagnostic, pharmaceutical and biotechnology industries.

Greiner Labortechnik started out in 1963 in Nürtingen, producing the first plastic Petri dishes. A further production facility that opened in Austria in 1974 also initially manufactured Petri dishes.

In the 1980s, Greiner unveiled VACUETTE ­ the first evacuated blood collection system with a plastic safety cap ­ which can maintain a vacuum for at least 18 months.

This extremely important innovation was key in shaping the company’s further development. Another major breakthrough came in 1997 with the world’s first 1536 well microplate.

In 1988, an ultramodern 15,000 square metre injection moulding production facility opened in Frickenhausen, near Nürtingen. The company also invested in a new production site in the United States and, in 2001, Greiner Labortechnik became Greiner Bio-One International AG.

With a global turnover of 364 million euros, Greiner now has over 1,700 employees spread across seven production facilities and 24 subsidiaries in countries such as France, the Netherlands, Belgium, the United Kingdom, Japan, Hungary, the United States, Switzerland, Brazil, Thailand, China and India.

Based in the Austrian town of Kremsmünster, the Preanalytics division supplies hospitals, clinical laboratories, blood donation centres and the diagnostics industry with complete solutions for venous and capillary blood collection.

Innovations include safety products to protect against needlestick injuries and the VACUETTE PREMIUM tubes with a special screw cap that protect health service professionals against infections.

The division’s latest development is the VACUETTE TUBE TOUCH safety holder. When inserting the tube into the holder, a mechanism activates a safety cap to ensure risk-free blood collection.

The Diagnostics division focuses on DNA chip technology. Biochips provide conclusive proof of the specific genetic fingerprints of many different parameters in a single analysis. The CarnoCheck DNA chip, for example, detects traces of various animal species in food products.

A further significant Greiner Bio-One innovation is the PapilloCheck HPV test, which reliably identifies and flags up 24 strains of the human papillomavirus (HPV). This has taken Greiner Bio-One a big step forward in the early detection of a virus that is the main cause of cervical cancer.

Headed by managing director Heinz Schmid, the German headquarters of the BioScience division in Frickenhausen control all research and development activities in the Cell Culture, High-Throughput Screening and OEM product sectors for markets throughout the world.

Schmid, who started his career as a trainee at the company, sees the anniversary as more than simply an excuse for nostalgia. “I share my staff’s great pride when I see the trust placed in Greiner Bio-One products by scientists and doctors working in areas such as cancer research, virus diagnostics and vaccine production the world over. We are committed to always delivering optimum solutions with our innovations,” he says.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Big Plans and 40 Years of Experience
Rudi Vollmer becomes new Technical Managing Director of Greiner Bio-One GmbH, responsible for production and technology.
Tuesday, June 30, 2015
Scientific News
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
Molecular Map Provides Clues To Zinc-Related Diseases
Mapping the molecular structure where medicine goes to work is a crucial step toward drug discovery against deadly diseases.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
Angina Drug Could Inform A New Strategy To Fight Cryptococcosis
A drug, more commonly used in the treatment of angina, could be the focus of a new strategy in fighting the fatal fungal infection cryptococcosis.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!